Evidence map›Paper›PMID 39415254›Full record

ArticleCell communication and signaling : CCS2024

Illuminating the dark kinome: utilizing multiplex peptide activity arrays to functionally annotate understudied kinases.

Abdul-Rizaq Hamoud, Khaled Alganem, Sean Hanna, Michael Morran, Nicholas Henkel, Ali S Imami, William Ryan, Smita Sahay, Priyanka Pulvender, Austin Kunch and 5 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abdul-Rizaq HamoudDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Khaled AlganemDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Sean HannaDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Michael MorranDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Nicholas HenkelDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Ali S ImamiDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
William RyanDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Smita SahayDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Priyanka PulvenderDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Austin KunchDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Taylen O ArvayDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA.
Jarek MellerDepartment of Biomedical Informatics, University of Cincinnati, Cincinnati, OH, USA.
Rammohan ShuklaDepartment of Zoology and Physiology, University of Wyoming, Laramie, WY, USA.
Sinead M O'DonovanDepartment of Biological Sciences, University of Limerick, Castletroy, Limerick, Ireland.
Robert McCullumsmithDepartment of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, USA. robert.mccullumsmith@utoledo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein kinases are critical components of a myriad biological processes and strongly associated with various diseases. While kinase research has been a point of focus in biomedical research for several decades, a large portion of the kinome is still considered understudied or "dark," because prior research is targeted towards a subset of kinases with well-established roles in cellular processes. We present an empirical and in-silico hybrid workflow to extend the functional knowledge of understudied kinases. Utilizing multiplex peptide activity arrays and robust in-silico analyses, we extended the functional knowledge of five dark tyrosine kinases (AATK, EPHA6, INSRR, LTK, TNK1) and explored their roles in schizophrenia, Alzheimer's dementia (AD), and major depressive disorder (MDD). Using this hybrid approach, we identified 195 novel kinase-substrate interactions with variable degrees of affinity and linked extended functional networks for these kinases to biological processes that are impaired in psychiatric and neurological disorders. Biochemical assays and mass spectrometry were used to confirm a putative substrate of EPHA6, an understudied dark tyrosine kinase. We examined the EPHA6 network and knowledgebase in schizophrenia using reporter peptides identified and validated from the multi-plex array with high affinity for phosphorylation by EPHA6. Identification and confirmation of putative substrates for understudied kinases provides a wealth of actionable information for the development of new drug treatments as well as exploration of the pathophysiology of disease states using signaling network approaches.

Indexed as

PeptidesHumansMajor Depressive DisorderPhosphorylationProtein Array AnalysisProtein KinasesSchizophreniaPeptidesProtein Kinases

Identifiers

PMID39415254
PMCPMC11484317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.